Colgate-Palmolive (CL) director Bilbrey granted 265 shares as deferred compensation

Rhea-AI Filing Summary

Colgate-Palmolive director John P. Bilbrey reported a compensation-related share award. He acquired 265 shares of Common Stock at $89.45 per share as a grant or award, increasing his direct holdings to 40,229 shares. A separate entry reflects 4,719 shares held indirectly by a trust. The footnote explains that a portion of his annual cash retainer was deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors, indicating this was part of routine director compensation rather than an open-market purchase.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider BILBREY JOHN P

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	265	$89.45	$24K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 40,229 shares (Direct, null); Common Stock — 4,719 shares (Indirect, By Trust)

Footnotes (1)

1. [object Object]

Key Figures

Share grant: 265 shares Grant reference price: $89.45 per share Direct holdings after grant: 40,229 shares +1 more

4 metrics

Share grant 265 shares Grant or award of Common Stock (Code A)

Grant reference price $89.45 per share Price per share for the 265-share award

Direct holdings after grant 40,229 shares Total Common Stock held directly after transaction

Indirect holdings by trust 4,719 shares Common Stock held indirectly by trust

Key Terms

Deferred Compensation Plan for Non-Employee Directors, annual cash retainer, stock unit account

3 terms

Deferred Compensation Plan for Non-Employee Directors financial

"pursuant to the Deferred Compensation Plan for Non-Employee Directors."

annual cash retainer financial

"Portion of annual cash retainer deferred to a stock unit account"

stock unit account financial

"deferred to a stock unit account pursuant to the Deferred Compensation Plan"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:17 PM Accepted by SEC EDGAR 07/02/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What did Colgate-Palmolive (CL) director John P. Bilbrey report in this Form 4?

John P. Bilbrey reported receiving a grant of 265 shares of Colgate-Palmolive Common Stock at $89.45 per share. The award stems from deferred director compensation rather than an open-market trade, and increases his disclosed direct holdings to 40,229 shares.

Was the Colgate-Palmolive (CL) Form 4 transaction a market buy or a compensation grant?

The Form 4 shows a compensation grant, not a market purchase. Code A identifies a grant or award, and the footnote states a portion of Bilbrey’s annual cash retainer was deferred into a stock unit account under the Deferred Compensation Plan.

How many Colgate-Palmolive (CL) shares does John P. Bilbrey hold after this transaction?

After the reported grant, Bilbrey holds 40,229 shares of Colgate-Palmolive Common Stock directly. A separate holding entry shows an additional 4,719 shares held indirectly by a trust, reflecting both direct and indirect ownership positions in the filing.

What does the 265-share award in Colgate-Palmolive (CL) represent for John P. Bilbrey?

The 265-share award represents a portion of Bilbrey’s annual cash retainer deferred into equity. The filing links it to the Deferred Compensation Plan for Non-Employee Directors, indicating routine director compensation rather than discretionary buying or selling activity in the market.

How is the indirect Colgate-Palmolive (CL) ownership reported for John P. Bilbrey?

The Form 4 includes an entry for 4,719 Colgate-Palmolive shares held indirectly "By Trust." This indicates those shares are owned through a trust arrangement, separate from Bilbrey’s 40,229 directly held shares, and clarifies the nature of his indirect beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BILBREY JOHN P

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		265	A	$89.45	40,229	D
Common Stock								4,719	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

	/s/ Kristine Hutchinson, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)